Managing Cancer Depression: A Whole Person Approach - CancerChoices



Managing Cancer Depression: A Whole Person Approach

Managing depression can help you maintain your daily activities and relationships and improve your quality of life. Reducing depression can boost your ability to make skillful choices about your care and cope with cancer treatment.

Depression at a glance

Depression—a mood disorder that causes a persistent feeling of sadness and loss of interest—is common among people with cancer. Symptoms include, but are not limited to, sadness, loss of motivation or interest in activities, and trouble focusing or making decisions.

The relationship between depression and terrain factors with known links to cancer, such as inflammation, pain, and hormone imbalances, is intricate and often goes both ways: depression can contribute to physical health issues, and physical health issues can, in turn, exacerbate or trigger depression. If you are depressed, getting treatment and breaking this feedback loop may be an important part of your cancer care.

Depression is treatable. Seek professional help if you need it: diagnoses such as depression can require therapy or medication from trained practitioners. Complementary approaches can also help you manage depression. Mind-body therapies, certain supplements and natural products, and therapies that manipulate your body or bioenergy fields have been helpful for some people. Depression may also be a symptom of stress. If stress is contributing to your depression, reducing your stress will be crucial to managing your depression.

Taking care of your mental health is as important as taking care of your physical health.

On this page

Depression: an overview

What is depression?

Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest.1Depression (major depressive disorder). Mayo Clinic. Viewed July 17, 2024. It can affect anyone, including people with cancer: about one in four people with cancer may experience severe depression.2Depression PDQ: Health Professional Version. National Cancer Institute. July 9, 2024. Viewed July 17, 2024. Some people may already have been depressed before learning they have cancer, and having cancer may affect their depression. Most importantly, depression is treatable.

Severe depression, called major depressive disorder or major depression, affects relationships and day-to-day life, making it difficult to function. While sadness and anxiety are normal reactions to getting a cancer diagnosis, these reactions tend to fluctuate over time. They may ease as you come to terms with the situation3Stanton AL, Snider PR. Coping with a breast cancer diagnosis: a prospective study. Health Psychology. 1993 Jan;12(1):16-23 and should not severely interfere with your ability to carry out daily activities or make decisions.4Depression PDQ: Health Professional Version. National Cancer Institute. July 9, 2024. Viewed July 17, 2024. 

Depression may make it harder to cope with and finish your cancer treatment.5Lin C, Clark R, Tu P, Bosworth HB, Zullig LL. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers. Breast Cancer Research and Treatment. 2017 Sep;165(2):247-260. It may affect your body’s defenses against cancer, or interfere with your ability to make choices about your care.
Most importantly, depression is treatable, and addressing it is a key part of managing your health.6Depression PDQ: Health Professional Version. National Cancer Institute. July 9, 2024. Viewed July 17, 2024.

Depression and cancer

Depression affects not only mental health but also physical health: it has been associated with higher risks of cancer,7Wang YH, Li JQ et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Molecular Psychiatry. 2020 Jul;25(7):1487-1499. recurrence,8Wang X, Wang N et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Molecular Psychiatry. 2020 Dec;25(12):3186-3197. and cancer-related death.9Prasad SM, Eggener SE et al. Effect of depression on diagnosis, treatment, and mortality of men with clinically localized prostate cancer. Journal of Clinical Oncology. 2014 Aug 10;32(23):2471-8; Faller H, Bülzebruck H, Drings P, Lang H. Coping, distress, and survival among patients with lung cancer. Archives of General Psychiatry. 1999 Aug;56(8):756-62; Wang YH, Li JQ et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Molecular Psychiatry. 2020 Jul;25(7):1487-1499; Wang X, Wang N et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Molecular Psychiatry. 2020 Dec;25(12):3186-3197; Liang X, Margolis KL et al. Effect of depression before breast cancer diagnosis on mortality among postmenopausal women. Cancer. 2017 Aug 15;123(16):3107-3115. Depression is also linked to body terrainthe internal conditions of your body, including nutritional status, fitness, blood sugar balance, hormone balance, inflammation and more factors important in cancer, including body weight,10Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga P. Waist to hip ratio in middle-aged women. Associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arteriosclerosis and Thrombosis. 1991 Sep-Oct;11(5):1250-7. hormone imbalances,11Tu KY, Wu MK et al. Significantly higher peripheral insulin-like growth factor-1 levels in patients with major depressive disorder or bipolar disorder than in healthy controls: a meta-analysis and review under guideline of PRISMA. Medicine (Baltimore). 2016 Jan;95(4):e2411; Strittmatter M, Bianchi O et al. Funktionsstörung der hypothalamisch-hyphophysär-adrenalen Achse bei Patienten mit akuten, chronischen und intervallartigen Schmerzsyndromen [Altered function of the hypothalamic-pituitary-adrenal axis in patients with acute, chronic and episodic pain] German. Schmerz. 2005 Apr;19(2):109-16. immune function,12Schutte NS, Malouff JM. The association between depression and leukocyte telomere length: a meta-analysis. Depression and Anxiety. 2015 Apr;32(4):229-38; Levy SR, Herberman ML et al. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. Journal of Clinical Oncology. 1987 Mar;5(3):348-53. inflammation,13Wittenberg GM, Stylianou A et al; MRC ImmunoPsychiatry Consortium. Effects of immunomodulatory drugs on depressive symptoms: a mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders. Molecular Psychiatry. 2020 Jun;25(6):1275-1285; Abbott R, Whear R et al. Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety. Journal of Psychosomatic Research. 2015 Sep;79(3):175-84; Hiles SA, Baker AL, de Malmanche T, Attia J. Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. Psychological Medicine. 2012 Oct;42(10):2015-26. and your microbiomethe collection of microbes living on and within your body.14Naseribafrouei A, Hestad K et al. Correlation between the human fecal microbiota and depression. Neurogastroenterology and Motility. 2014 Aug;26(8):1155-62. These links are complex, and cause and effect can go both ways. Depression may lead to worse health; conversely, inflammation, poor health, and facing a serious diagnosis may contribute to depression. Since there is scientific evidence of these links, managing your depression is one step you can take to improve your cancer outcomes.

What can cause depression?

According to the National Cancer Institute, “Sadness and grief are normal reactions to the crises faced during cancer. All people will experience these reactions periodically. A cancer diagnosis, ongoing treatment, and adverse effects of treatment, such as sexual difficulties, can all increase risk of depression.”15Hein I. Sexual distress, depression after prostate cancer treatment. Medscape. May 20, 2020. Viewed June 23, 2023; Tsao PA, Ross RD, Bohnert ASB, Mukherjee B, Caram MEV. Depression, anxiety, and patterns of mental health care among men with prostate cancer receiving androgen deprivation therapy. Oncologist. 2022 Apr 5;27(4):314-322; Dinh KT, Reznor G et al. Association of androgen deprivation therapy with depression in localized prostate cancer. Journal of Clinical Oncology. 2016 Jun 1;34(16):1905-12; Polacek LC, Nelson CJ. Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy: a psychological perspective. Cancer. 2019 Apr 1;125(7):1027-1029. 

Certain medications—such as steroids, interleukin-2 (IL-2), some chemotherapy drugs, and many more—may contribute to depression.16Depression PDQ: Health Professional Version. National Cancer Institute. July 9, 2024. Viewed July 17, 2024.

Medical conditions

Several medical conditions are linked to higher risk of depression.

Anxiety

Depression can be triggered by an anxiety disorder; many people have a diagnosis of both anxiety and depression.17Sawchuk CN. Depression and anxiety: Can I have both? Mayo Clinic. June 2, 2017. Viewed July 17, 2024. Fixating on worst-case outcomes (catastrophizing) is also linked to higher risk of depression.18Fischer DJ, Villines D, Kim YO, Epstein JB, Wilkie DJ. Anxiety, depression, and pain: differences by primary cancer. Supportive Care in Cancer. 2010 Jul;18(7):801-10.

Pain

Pain is linked to higher risk of depression.19Tarrasch J, England P, Hurst VT, McDonald D, O’Keefe R, Cipriano C. Patients with metastatic disease are at highest risk for anxiety and depression in an orthopedic oncology patient population. JCO Oncology Practice. 2022 Jun 1:OP2100905. Pain may worsen depression, and depression may worsen pain.20Charalambous A, Giannakopoulou M, Bozas E, Paikousis L. Parallel and serial mediation analysis between pain, anxiety, depression, fatigue and nausea, vomiting and retching within a randomised controlled trial in patients with breast and prostate cancer. BMJ Open. 2019 Jan 24;9(1):e026809; Joyce C, Roseen EJ et al. Can yoga or physical therapy for chronic low back pain improve depression and anxiety among adults from a racially diverse, low-income community? A secondary analysis of a randomized controlled trial. Archives of Physical Medicine and Rehabilitation. 2021 Jun;102(6):1049-1058; Ciaramella A, Poli P. Assessment of depression among cancer patients: the role of pain, cancer type and treatment. Psycho-oncology. 2001 Mar-Apr;10(2):156-65. Alleviating either depression or pain to interrupt the feedback loop between the two conditions may provide relief from both symptoms. See Pain › 

Diabetes and high blood sugar

Diabetes,21Bădescu SV, Tătaru C et al. The association between diabetes mellitus and depression. Journal of Medicine and Life. 2016 Apr-Jun;9(2):120-5. high blood sugar,22Winokur A, Maislin G, Phillips JL, Amsterdam JD. Insulin resistance after oral glucose tolerance testing in patients with major depression. American Journal of Psychiatry 1988; 145:325-30. and insulin resistance23Nathan RS, Sachar EJ, Asnis GM, Halbreich U, Halpern FS. Relative insulin insensitivity and cortisol secretion in depressed patients. Psychiatry Research. 1981;4:291-300; Weber B, Schweiger U, Deuschle M, Heuser I. Major depression and impaired glucose tolerance. Experimental and Clinical Endocrinology & Diabetes. 2000;108(3):187-90; Okamura F, Tashiro A et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism. 2000 Oct;49(10):1255-60. are also linked to depression. See High Blood Sugar and Insulin Resistance ›

Poor functional status

Your inability to take care of yourself and be mobile and independent at home or in your community is linked to higher risk of depression.24Chen ML, Chang HK, Yeh CH. Anxiety and depression in Taiwanese cancer patients with and without pain. Journal of Advanced Nursing. 2000 Oct;32(4):944-51.

What are the signs or symptoms of depression?

Suicidal thoughts

Suicidal thoughts require urgent attention. 

If you experience suicidal thoughts, it’s crucial to seek help immediately by contacting a physician or mental health provider.

In the US, the National Suicide Prevention Lifeline is open 24 hours a day, seven days a week, at 800-273-8255. The International Association for Suicide Prevention provides information on crisis centers and helplines around the world. 

If someone you know is having suicidal thoughts, you can help. 

American Foundation fo Suicide Prevention logo

If Someone Tells You They’re Thinking about Suicide: A #RealConvo Guide from AFSP ›

An excellent guide for what you can do if a loved one indicates they are having suicidal thoughts

The steps AFSP advises you to take if your loved one is in immediate danger:

  • Stay with them
  • Help them remove lethal means
  • Call the National Suicide Prevention Lifeline: 1-800-273-8255
  • Text TALK to 741741 to text with a trained crisis counselor from the Crisis Text Line free of cost, 24/7
  • Encourage them to seek help or to contact their doctor or therapist

Other signs and symptoms

Depression can manifest through a variety of symptoms, such as these: 

  • Mood-related: feelings of sadness, hopelessness, irritability, numbness, worthlessness, or anxiety
  • Behavioral: loss of interest in activities, withdrawal from social interactions, frequent crying, or lack of motivation
  • Cognitive: difficulty focusing or making decisions, memory problems, or negative thoughts
  • Physical: fatigue, changes in appetite, sleep disturbances, or sexual problems

Because cognitive and physical symptoms may be side effects of your cancer or cancer treatment, doctors place more emphasis on mood-related and behavioral symptoms when diagnosing depression with cancer.25Depression PDQ: Health Professional Version. National Cancer Institute. July 9, 2024. Viewed July 17, 2024.

Top evidence-based practices and therapies for managing depression 

Seek professional help if needed. Diagnoses such as depression can require therapy from trained practitioners for management. We encourage you to explore the options available to you through your cancer team and others. Taking care of your mental health is as important as taking care of your physical health.

SIO-ASCO clinical practice guidelines recommendations

Society for Integrative Oncology and American Society for Clinical Oncology logos

In 2023, the Society for Integrative Oncology and the American Society of Clinical Oncology published Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults with Cancer.

These recommendations are based on a rigorous review of complementary therapies with a high level of evidence. Therapies are recommended in the guidelines for different phases of cancer treatment. Many of these therapies are also recommended in other clinical practice guidelines for people with cancer26Greenlee H, DuPont-Reyes MJ et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA: A Cancer Journal for Clinicians. 2017 May 6;67(3):194-232—this set of guidelines has been endorsed by the American Society of Clinical Oncology (ASCO): Lyman GH, Greenlee H et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. Journal of Clinical Oncology. 2018 Sep 1;36(25):2647-2655; Deng GE, Rausch SM et al. Complementary therapies and integrative medicine in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):e420S-e436S; Deng GE, Frenkel M et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. Journal of the Society for Integrative Oncology. 2009 Summer;7(3):85-120. or for adults with major depressive disorder.27Ravindran AV, Balneaves LG et al; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5. complementary and alternative medicine treatments. Canadian Journal of Psychiatry. 2016 Sep;61(9):576-87.

Recommended both during and after cancer treatment

Recommended during cancer treatment

Recommended after cancer treatment

Recommendation against use; should be avoided

  • Expressive writing

Other practices and therapies

In addition to the therapies recommended in the guideline above, these practices and therapies have modestsignificant effects in at least three small but well-designed RCTs, or one or more well-designed, mid-sized clinical studies of reasonably good quality (RCTs or observational studies), or several small studies aggregated into a meta-analysis (this is the CancerChoices definition; other researchers and studies may define this differently), goodsignificant effects in one large or several mid-sized and well-designed clinical studies (RCTs with an appropriate placebo or other strong comparison control or observational studies that control for confounds (this is the CancerChoices definition; other researchers and studies may define this differently), or strongconsistent, significant effects in several large (or at least one very large) well designed clinical studies or at least two meta-analyses of clinical studies of moderate or better quality (or one large meta-analysis) finding similar results (this is the CancerChoices definition; other researchers and studies may define this differently) evidence of effectiveness for managing depression among people with cancer or depression.

If your depression is a symptom of other medical conditions such as those mentioned above, you may need to treat the underlying condition to address the cause of your depression.

Conventional therapies 

Various prescription drugs may help manage depression. Ask your doctor for recommendations, but also ask about side effects from their use. Many of the lifestyle practices and complementary therapies described on this page have fewer side effects than prescription drugs.

Psychosocial therapies are also widely used to treat depression. These are recommended in integrative practice guidelines for managing depression among people with cancer either individually or in groups:28Li M, Kennedy EB et al. Management of depression in patients with cancer: a clinical practice guideline. Journal of Oncology Practice. 2016 Aug;12(8):747-56; Deng GE, Rausch SM et al. Complementary therapies and integrative medicine in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):e420S-e436S; Deng GE, Frenkel M et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. Journal of the Society for Integrative Oncology. 2009 Summer;7(3):85-120.

  • Cognitive-behavioral therapy
  • Cognitive-behavioral stress management (CBSM)
  • Psychoeducation
  • Supportive/expressive therapy
  • Guided self-help programs based on cognitive behavioral therapy (CBT), behavioral activation, or problem-solving techniques
  • Behavioral couples’ therapy

Several treatments that stimulate nerves are recommended in clinical practice guidelines for treating adults with major depressive disorder:29Milev RV, Giacobbe P et al; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. neurostimulation treatments. Canadian Journal of Psychiatry. 2016 Sep;61(9):561-75.

  • Electroconvulsive therapy (ECT)
  • Repetitive transcranial magnetic stimulation (rTMS)
  • Transcranial direct current stimulation (tDCS)
  • Vagus nerve stimulation

Lifestyle practices

Complementary therapies 

Not all therapies may be recommended during some cancer treatments, as noted.

For guidance in selecting and using complementary therapies, see Finding Integrative Oncologists and Other Practitioners ›

Supplements and natural products
Other complementary therapies
Therapies not as appropriate for people with cancer

These therapies are recommended in practice guidelines for people with clinical depression but have safety concerns among people with cancer:

  • Acetyl-L-carnitine
  • Folate, also called vitamin B9
  • S-adenosyl-L-methionine (SAMe)
  • St. John’s wort
  • Sleep deprivation

For health professionals

Suicide

Find guidance for health professionals: Suicide among people with cancer › 

Links for professionals 

Fasinu PS, Rapp GK. Herbal interaction with chemotherapeutic drugs—a focus on clinically significant findings. Frontiers in Oncology. 2019 Dec 3;9:1356.

Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J. Herbal medicine for depression and anxiety: a systematic review with assessment of potential psycho-oncologic relevance. Phytotherapy Research. 2018 May;32(5):865-891.

In their book, Donald Abrams and Andrew Weil mention interventions that can be helpful, including mind-body interventions, cannabis, and—with caution about use with some chemotherapy drugs—St. John’s wort.63Abrams DI, Weil AT. Integrative Oncology, 2nd Edition. New York, NY: Oxford University Press. 2014.

Authors

Laura Pole, MSN, RN, OCNS

Senior Clinical Consultant
View profile

Laura Pole is senior clinical consultant for CancerChoices. Laura is an oncology clinical nurse specialist who has been providing integrative oncology clinical care, navigation, consultation, and education services for over 40 years. She is the co-creator and co-coordinator of the Integrative Oncology Navigation Training at Smith Center for Healing and the Arts in Washington, DC. Laura also manages the “Media Watch Cancer News That You Can Use” listserv for Smith Center/Commonweal. In her role as a palliative care educator and consultant, Laura has served as statewide Respecting Choices Faculty for the Virginia POST (Physician Orders for Scope of Treatment) Collaborative as well as provided statewide professional education on palliative and end-of-life care for the Virginia Association for Hospices and Palliative Care.

For CancerChoices, Laura curates content and research, networks with clinical and organizational partners, brings awareness and education of integrative oncology at professional and patient conferences and programs, and translates research into information relevant to the patient experience as well as clinical practice.

Laura sees her work with CancerChoices as a perfect alignment of all her passions, knowledge and skills in integrative oncology care. She is honored to serve you.

Laura Pole, MSN, RN, OCNS Senior Clinical Consultant

Nancy Hepp, MS

Lead Researcher
View profile

Ms. Hepp is a researcher and communicator who has been writing and editing educational content on varied health topics for more than 20 years. She serves as lead researcher and writer for CancerChoices and also served as the first program manager. Her graduate work in research and cognitive psychology, her master’s degree in instructional design, and her certificate in web design have all guided her in writing and presenting information for a wide variety of audiences and uses. Nancy’s service as faculty development coordinator in the Department of Family Medicine at Wright State University also provided experience in medical research, plus insights into medical education and medical care from the professional’s perspective.

Nancy Hepp, MS Lead Researcher

Jane Liaw is a science writer and the assistant director of Art of Writing at UC Berkeley. She previously worked at the UC Berkeley School of Public Health as a researcher, program and grants administrator, and scientific writer and editor. She holds an MPH in Environmental Health Sciences from UC Berkeley, a graduate degree in science communication from UC Santa Cruz, and a BS in Earth Systems from Stanford University.

Jane Liaw, MPH

Maria Williams

Research and Communications Consultant
View profile

Maria Williams is a research and communications consultant who brings over 15 years’ experience in research, consumer education, and science communication to CancerChoices. She has worked primarily in public health and environmental health.

Maria Williams Research and Communications Consultant

Reviewers

Christine Mineart, MPH

CancerChoices Program Director
View profile

Christine has a dynamic background in the life sciences, public health, and program operations. Her career began at the lab bench with a Gates Foundation-funded HIV Vaccine research group, which led her to graduate studies in public health epidemiology at UC Berkeley. Her research experience spans clinical epidemiology research to evaluating the impacts of community nutrition programs in Los Angeles, the Central Valley, and Oakland. Most recently she has worked in executive operations for a seed-stage venture capital firm based in San Francisco. Personally, Christine is passionate about holistic health and wellness. She is a clinical herbalist and Reiki master, and she has been practicing yoga for 15+ years. She brings a breadth of experiences to her work leading the CancerChoices program.

Christine Mineart, MPH CancerChoices Program Director

Miki Scheidel

Co-Founder and Creative Director
View profile

Miki Scheidel is Co-founder and creative director of CancerChoices. She led the effort to transform Beyond Conventional Cancer Therapies, the prior version of CancerChoices, to its current form. Miki and her family were deeply affected by her father’s transformative experience with integrative approaches to metastatic kidney cancer. That experience inspires her work as president of the Scheidel Foundation and as volunteer staff at CancerChoices. She previously worked with the US Agency for International Development and Family Health International among other roles. She received her graduate degree in international development from Georgetown University, a graduate certificate in nonprofit management from George Mason University, and a Bachelor of Arts from Gettysburg College.

Miki Scheidel Co-Founder and Creative Director

Last update: September 18, 2024

Last full literature review: November 2021

CancerChoices provides information about integrative in cancer care, a patient-centered approach combining the best of conventional care, self care and evidence-informed complementary care in an integrated plan cancer care. We review complementaryin cancer care, complementary care involves the use of therapies intended to enhance or add to standard conventional treatments; examples include supplements, mind-body approaches such as yoga or psychosocial therapy, and acupuncture therapies and self-care lifestyle actions and behaviors that may impact cancer outcomes; examples include eating health-promoting foods, limiting alcohol, increasing physical activity, and managing stress practices to help patients and professionals explore and integrate the best combination of conventionalthe cancer care offered by conventionally trained physicians and most hospitals; examples are chemotherapy, surgery, and radiotherapy and complementary therapies and practices for each person.

Our staff have no financial conflicts of interest to declare. We receive no funds from any manufacturers or retailers gaining financial profit by promoting or discouraging therapies mentioned on this site.

Learn more

References[+]